<DOC>
	<DOCNO>NCT03018821</DOCNO>
	<brief_summary>Although incidence Hepatitis B decrease lot recently year , still quite chronic hepatitis B patient China . The anti-virus drug western medicine Entecavir Tenofovir prove effective decrease serum hepatitis B virus ( HBV ) level , hand , Chinese materia medica show effective TCM syndromes chronic hepatitis B ( CHB ) hypochondriac pain , jaundice abdominal mass . Besides , hepatic fibrosis could delay appropriate treatment TCM . This study multicenter , randomize , open label , parallel group clinical trial evaluate efficacy two different traditional Chinese medicine ( TCM ) herbal treatment chronic hepatitis B .</brief_summary>
	<brief_title>The Study Two Different Chinese Traditional Medicine Treatment Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>18 &lt; =age treatment &lt; =65 year old Was diagnose chronic hepatitis B ( ICD10 : K73.901 ) one follow Chinese syndrome : hypochondriac pain ( TCD : BNG010 ) , jaundice ( TCD : BNG020 ) abdominal mass ( TCD : BNG040 ) . Combined virus hepatitis alcoholic hepatitis Combined autoimmune disease Combined liver cancer cirrhosis Combined severe hepatitis without complication Combined unstable cardiocerebrovascular disease Combined severe lung , kidney , endocrine system , nervous system hematological system disease Combined Tuberculosis Chronic hepatitis patient ongoing INF treatment Woman pregnancy breast feed Mental disorder express self clearly Can speak Chinese Allergic constitution allergy multiple drug Refuse enroll study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>